IMO to release free COVID-19 terminology content and value sets

With the unprecedented global outbreak of COVID-19, the novel coronavirus, it’s crucial that we all do our part to help. At IMO, that means ensuring clinicians can easily identify and monitor COVID-19 patients using the most up-to-date terms for EHR documentation. IMO's CEO Ann Barnes describes our new offerings, available free of charge on March 26.
Share on facebook
Share on twitter
Share on linkedin
Share on email
COVID19-Terminology-Value-Sets

Given the rapid spread of COVID-19, the need to accurately document and diagnose new cases of the novel coronavirus is critical to patients, their communities, and the healthcare professionals who serve them. While we wish IMO’s expertise was not needed, this global pandemic is a unique opportunity to support our provider partners around the world in ways that only IMO can.

On January 30, IMO released 15 new descriptors to help clinicians more accurately record diagnoses related to COVID-19. On March 26, as part of our March problem terminology release, that number will increase to 136 terms. In addition, IMO has created IMO Precision COVID-19 Sets, which includes two new value sets aimed at helping providers with workflow and cohort management connected to the coronavirus. IMO Precision COVID-19 Sets will be made available to all customers, completely free of charge, helping them to:

  • Leverage health information systems to identify and monitor patients who have documented COVID-19 problems and diagnoses
  • Analyze the effectiveness of an institution’s COVID-19 management protocol

As CEO, I am proud of the IMO teams that have collaborated so quickly to meet this unprecedented challenge. Rest assured that we are focused on our employees’ health and safety as they continue do the important work that supports you in your vital missions. We will closely monitor the situation and, as needed, add to COVID-19 resources to help the global health community monitor, manage, and slow the spread of this disease.

For those unfamiliar with IMO Precision Sets, here is the link to a video that explains the solution and how it can be accessed. IMO will further communicate to the market and our customers on March 26 with more details on the complimentary software release.

Ann Barnes joined IMO in 2018 as Chief Executive Officer, leading the company’s day-to-day operations. In November 2008, she joined MedData as Vice President of Client Services and rose quickly to the position of Chief Operating Officer. In February 2013, Ann was promoted to President, then to CEO soon after. She also served on their Board of Directors. Ann is a graduate of the University of the Pacific in San Francisco where she earned a bachelor’s degree in Business Administration and Marketing.
About Intelligent Medical Objects (IMO)

At IMO, we are dedicated to powering care as you intended, through a platform that is intelligent, intuitive, and intentional. Used by more than 4,500 hospitals and 500,000 physicians daily, IMO’s clinical interface terminology (CIT) forms the foundation for healthcare enterprise needs including effective management of EHR problem lists, accurate documentation, and the mapping of over 2.4 million clinician-friendly terms across 24 different code systems.

We offer a portfolio of products that includes terminologies and value sets that are clinically vetted, always current, and maintenance-free. This aligns to provider organizations’ missions, EHR platforms’ inherent power, and the evolving vision of the healthcare industry while ensuring accurate care documentation and administrative codes. So clinicians can get back to being clinicians, health systems can get reimbursed, and patients can more easily engage in their own care. As intended.

© 2020 Intelligent Medical Objects, Inc. All rights reserved.

Share on facebook
Share on twitter
Share on linkedin
Share on email

Related Ideas

How the past informs the present: Lessons learned from prior outbreaks

When the medical community encountered the Zika virus outbreak in 2015, IMO was ready to help with new terminology to document the disease. We learned some lessons in that situation – ones that are helping guide our response to the current novel coronavirus pandemic. IMO VP of Global Clinical Services, Steven Rube, MD, explains our past and current responses to these crises, and talks about how what we learned in 2015 is informing our efforts now.

Read More

Clinical terminology in a time of uncertainty

In the midst of the novel coronavirus pandemic, updates to COVID-19 coding guidelines, terms, and names are important for patient care, but challenging to manage. IMO’s clinical, product, and coding experts break down how COVID-19 terms have been developed and explain how IMO can help providers by taking terminology concerns off of their plates.

Read More